Home

"HPV detection and vaccination is a major step forward in cervical cancer eradication. But an HPV infection is not treatable, and in most cases self-resolves. Thus, a secondary collection of a cervical sample for cytology analysis is required to treat a patient, continuing to be a barrier to screening access in under-served populations. We've resolved that with the world's 1st self-collection device that captures cervical cells suitable for both HPV and cellular analysis,. It's CE marked for European distribution, and we have done several studies demonstrating efficacy and are amidst an FDA study intended to lead to 510(k) submission. Additional IP exists that will allow a woman to fully test herself not just for HPV, but for treatable disease without the need for an in-office visit (think 'pregnancy test')."